EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,871,484 | +319.1% | 65,967 | +331.8% | 0.00% | +300.0% |
| Q4 2022 | $446,517 | -54.4% | 15,276 | -34.9% | 0.00% | -75.0% |
| Q1 2021 | $979,000 | -66.4% | 23,449 | -54.5% | 0.00% | -82.6% |
| Q3 2019 | $2,918,000 | +47.4% | 51,590 | +45.1% | 0.02% | +43.8% |
| Q2 2019 | $1,979,000 | -61.0% | 35,550 | -64.6% | 0.02% | -33.3% |
| Q1 2019 | $5,068,000 | +12.9% | 100,376 | -9.9% | 0.02% | -47.8% |
| Q4 2018 | $4,490,000 | +1878.0% | 111,464 | +2492.2% | 0.05% | +411.1% |
| Q1 2018 | $227,000 | -94.1% | 4,300 | -90.9% | 0.01% | -82.0% |
| Q2 2015 | $3,842,000 | – | 47,509 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |